CD7 and T-cell acute lymphoblastic leukemia: And CD7-specific nanobodies fused to PE38 showed cytotoxic efficacy in CD7-expressing T-cell acute lymphoblastic leukemia in vitro and in a preclinical mouse model in vivo (91, 92).